Pathophysiological Significance of Atrial Fibrillation Electrogram Patterns

心房颤动电图模式的病理生理学意义

基本信息

项目摘要

Atrial fibrillation (AF) is the most common heart rhythm disorder and is a major cause of stroke. Despite its rapidly rising incidence, current therapies are suboptimal. This is largely because current AF therapies, including ablation, are not targeted to the fundamental mechanisms underlying AF. AF is characterized by complex electrical activation patterns that are difficult to map using standard activation time mapping. Yet, there is growing evidence that AF is driven by stable sources in the atria, such as rotors or focal activity. Unfortunately, previous attempts to use AF electrograms to detect these sources have had mixed success. We have recently developed an electrogram morphology recurrence (EMR) analysis that appears to more accurately reflect molecular and electrophysiological substrate for AF than previously described AF electrogram measures of AF. Our recent studies suggest that regions of high recurrence morphology with the shortest cycle lengths (i.e. regions of low recurrence cycle length - CLR) may correspond to regions of increased parasympathetic innervation and/or increased oxidative injury. Furthermore, our clinical studies suggest that in patients with persistent AF, EMR mapping is both feasible and provides important physiologic information. Our overall hypothesis for this proposal is: ‘sites of high recurrence morphology with the shortest cycle length (i.e. CLR) represent regions of increased autonomic signaling and/or increased oxidative injury, which are critical to the maintenance of persistent AF.’ To test this hypothesis, we will use novel gene therapy approaches developed in our lab, as well as a CLR-guided ablation strategy in patients with persistent AF. In Specific Aim 1, we will assess in a canine rapid atrial pacing model of AF whether targeted inhibition of parasympathetic signaling – by expression of plasmids expressing Gαi/o inhibitory peptides (Gαi/o_ct) at the atrial sub-region with lowest CLR – will reverse electrical remodeling and AF. In Specific Aim 2, we will assess in the same canine model whether targeted inhibition one or more of the two major sources of oxidative injury in AF - by expression of NOX2 shRNA  mitochondrial catalase at the atrial sub-region with lowest CLR – will reverse electrical remodeling, prevent progression of fibrosis and decrease AF. In Specific Aim 3, patients with persistent AF who are undergoing catheter ablation will be randomized to a CLR guided ablation strategy or PVI alone; we will determine whether in these patients a CLR guided ablation strategy will increase ECG dominant frequency compared to PVI alone. Completion of all the aims will provide a clear path to using EMR mapping as a new diagnostic method to guide therapeutic intervention for AF. This proposal leverages the prior development and validation of EMR to test several novel targeted approaches for treating AF. As AF may have complex underlying pathophysiology, it is feasible that one or more of these approaches could be therapeutic and could ultimately be used in combination. This proposal provides a critical platform to advance the science of curative therapy for AF.
心房颤动(房颤)是最常见的心律失常,也是中风的主要原因。尽管它的 发病率迅速上升,目前的治疗方法并不理想。这在很大程度上是因为目前的房颤疗法, 包括消融,并不针对房颤的基本机制。AF的特点是 使用标准激活时间映射难以映射的复杂电激活模式。然而, 越来越多的证据表明,房颤是由心房内的稳定来源驱动的,例如转子或局部活动。 不幸的是,以前使用房颤电信号检测这些震源的尝试有成功也有成功。我们 最近开发了一种电信号形态复发(EMR)分析,似乎比 比之前描述的房颤更准确地反映了房颤的分子和电生理底物 房颤的心电图测量。我们最近的研究表明,具有高复发率的区域 最短循环长度(即,低循环循环长度的区域-CLR)可以对应于 副交感神经支配增加和/或氧化损伤增加。此外,我们的临床研究 提示在持续性房颤患者中,EMR标测既是可行的,又提供了重要的生理功能 信息。我们对这一提议的总体假设是:具有最短复发率的部位 周期长度(即CLR)代表自主神经信号增强和/或氧化损伤增加的区域, 这对维持持久的急性呼吸综合征至关重要。为了验证这一假设,我们将使用新的基因疗法。 我们实验室开发的方法,以及CLR指导下的持续性房颤患者的消融策略。在……里面 具体目标1,我们将评估在犬快速心房起搏模型中是否靶向抑制房颤 副交感神经信号转导--表达G-αI/O抑制肽(G-αI/o_ct)的表达 CLR最低的房亚区--将逆转电重构和房颤。在具体目标2中,我们将评估 在同一犬模型中,靶向抑制是氧化损伤的两个主要来源之一还是多个 房颤时CLR-Will最低的房室亚区NOX2shRNA线粒体过氧化氢酶的表达 逆转电重构,防止纤维化进展,减少房颤。在特定目标3中,患有 正在接受导管消融的持续性房颤患者将随机接受CLR引导的消融策略或 我们将确定在这些患者中,CLR引导的消融策略是否会增加心电图 与单独的PVI相比,主要频率。完成所有目标将为使用电子病历提供一条清晰的途径 标测作为一种新的诊断方法指导房颤的治疗干预。这项提议充分利用了 预先开发和验证EMR,以测试几种治疗房颤的新的靶向方法。因为房颤可能 有复杂的潜在病理生理学,这些方法中的一个或多个可能是可行的 治疗作用,并最终可用于联合使用。这项提议提供了一个关键的平台来推进 治疗房颤的科学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY J GOLDBERGER其他文献

JEFFREY J GOLDBERGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY J GOLDBERGER', 18)}}的其他基金

Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
  • 批准号:
    10330560
  • 财政年份:
    2021
  • 资助金额:
    $ 70.38万
  • 项目类别:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
  • 批准号:
    10553649
  • 财政年份:
    2021
  • 资助金额:
    $ 70.38万
  • 项目类别:
Trans-omic analysis of epicardial adipose tissue in atrial fibrillation
心房颤动心外膜脂肪组织的跨组学分析
  • 批准号:
    10096986
  • 财政年份:
    2021
  • 资助金额:
    $ 70.38万
  • 项目类别:
Novel medical adjunctive therapy to catheter ablation for atrial fibrillation
心房颤动导管消融的新型医学辅助疗法
  • 批准号:
    10113417
  • 财政年份:
    2019
  • 资助金额:
    $ 70.38万
  • 项目类别:
Path to Improved Risk Stratification
改进风险分层的途径
  • 批准号:
    9125490
  • 财政年份:
    2016
  • 资助金额:
    $ 70.38万
  • 项目类别:
Path to Improved Risk Stratification
改进风险分层的途径
  • 批准号:
    8719852
  • 财政年份:
    2014
  • 资助金额:
    $ 70.38万
  • 项目类别:
4D Magnetic Resonance Imaging for Atrial Flow Assessment in Atrial Fibrillation
4D 磁共振成像用于心房颤动心房血流评估
  • 批准号:
    8605912
  • 财政年份:
    2013
  • 资助金额:
    $ 70.38万
  • 项目类别:
4D Magnetic Resonance Imaging for Atrial Flow Assessment in Atrial Fibrillation
4D 磁共振成像用于心房颤动心房血流评估
  • 批准号:
    8445112
  • 财政年份:
    2013
  • 资助金额:
    $ 70.38万
  • 项目类别:
PHYSIOLOGY OF HEART RATE RECOVERY AFTER SUBMAXIMAL EXERCISE IN SUBJECTS WITH CAD
CAD 受试者次极量运动后心率恢复的生理学
  • 批准号:
    7604258
  • 财政年份:
    2006
  • 资助金额:
    $ 70.38万
  • 项目类别:
INFARCT CHARACTERISTICS DETERMINED BY CARDIAC MRI PREDICTIVE OF ARRHYTHMIC EVENT
通过心脏 MRI 确定的梗塞特征预测心律失常事件
  • 批准号:
    7604307
  • 财政年份:
    2006
  • 资助金额:
    $ 70.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了